ALKERMES | Omløpsmidler

Current Assets Endring Dato
AbbVie USD 38.87B 5.65B 2024-03
Amgen USD 28.03B 2.3B 2024-03
Biogen USD 6.76B 103.1M 2024-03
BioMarin Pharmaceutical USD 2.99B 28.92M 2024-03
Bristol-Myers Squibb USD 28.67B 1.04B 2024-03
Eli Lilly USD 25.19B 2.18B 2024-03
Gilead Sciences USD 14.04B 2.41B 2024-03
Intra Cellular Therapies USD 690.53M 22.73M 2024-03
Ionis Pharmaceuticals USD 2.42B 226.18M 2024-03
J&J USD 57B 3.3B 2024-03
Malin Corporation EUR 32.8M 142.3M 2023-06
Merck USD 31.44B 509M 2024-03
Neurocrine Biosciences USD 1.8B 149.1M 2024-03
Pfizer USD 42.42B 31.6B 2024-03
Regeneron Pharmaceuticals USD 18.87B 5.62B 2024-03
Vertex Pharmaceuticals USD 13.29B 1.41B 2024-03



ALKERMES Omløpsmidler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.